Article Details
Retrieved on: 2022-06-23 02:13:50
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Trial is expected to commence this summer. INDIANAPOLIS, May 13, 2022 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. ( PNT) (the “Company” or “POINT”) ...
Article found on: www.gurufocus.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here